To evaluate the in vivo relevance of resistance to platinum chemotherapy in EpCAM-positive cancer cells, iMOT cells were orthotopically transplanted into immunocompetent recipient mice, and recipient mice bearing ovarian tumors received intraperitoneal cisplatin or carboplatin treatment (Figure 3A). The gene discussed is EPCAM; the disease is cancer.